These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 36793271)
1. A novel pyroptosis gene expression-based risk score for survival in gastric cancer. Hu J; Song Y; Cai X; Halina H; Qiao K; Lu J; Yin C; Gao F Front Endocrinol (Lausanne); 2023; 14():1120216. PubMed ID: 36793271 [TBL] [Abstract][Full Text] [Related]
2. Construction and Validation of a Novel Pyroptosis-Related Four-lncRNA Prognostic Signature Related to Gastric Cancer and Immune Infiltration. Wang Z; Cao L; Zhou S; Lyu J; Gao Y; Yang R Front Immunol; 2022; 13():854785. PubMed ID: 35392086 [TBL] [Abstract][Full Text] [Related]
3. An innovative pyroptosis-related long-noncoding-RNA signature predicts the prognosis of gastric cancer Xiong S; Jin L; Zeng C; Ma H; Xie L; Liu S Pathol Oncol Res; 2022; 28():1610712. PubMed ID: 36567977 [No Abstract] [Full Text] [Related]
4. A Novel Glycolysis-Related Long Noncoding RNA Signature for Predicting Overall Survival in Gastric Cancer. Zeng J; Li M; Dai K; Zuo B; Guo J; Zang L Pathol Oncol Res; 2022; 28():1610643. PubMed ID: 36419649 [No Abstract] [Full Text] [Related]
5. A novel copper-induced cell death-related lncRNA prognostic signature associated with immune infiltration and clinical value in gastric cancer. Wang L; Xiao K; Dong Z; Meng T; Cheng X; Xu Y J Cancer Res Clin Oncol; 2023 Sep; 149(12):10543-10559. PubMed ID: 37291405 [TBL] [Abstract][Full Text] [Related]
6. Identification of a 6-lncRNA prognostic signature based on microarray re-annotation in gastric cancer. Ma B; Li Y; Ren Y Cancer Med; 2020 Jan; 9(1):335-349. PubMed ID: 31743579 [TBL] [Abstract][Full Text] [Related]
7. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma. Zhu W; Ye Z; Chen L; Liang H; Cai Q Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154 [TBL] [Abstract][Full Text] [Related]
8. Identifying a Novel Defined Pyroptosis-Associated Long Noncoding RNA Signature Contributes to Predicting Prognosis and Tumor Microenvironment of Bladder Cancer. Lu H; Wu J; Liang L; Wang X; Cai H Front Immunol; 2022; 13():803355. PubMed ID: 35154117 [TBL] [Abstract][Full Text] [Related]
9. Identification of a novel m6A-related lncRNA pair signature for predicting the prognosis of gastric cancer patients. Wang JM; Li X; Yang P; Geng WB; Wang XY BMC Gastroenterol; 2022 Feb; 22(1):76. PubMed ID: 35189810 [TBL] [Abstract][Full Text] [Related]
10. A novel endoplasmic reticulum stress-related lncRNA signature for prognosis prediction and immune response evaluation in Stomach adenocarcinoma. Song Z; Su M; Li X; Xie J; Han F; Yao J BMC Gastroenterol; 2023 Dec; 23(1):432. PubMed ID: 38066437 [TBL] [Abstract][Full Text] [Related]
11. Identification of a 14-lncRNA Signature and Construction of a Prognostic Nomogram Predicting Overall Survival of Gastric Cancer. Nie K; Deng Z; Zheng Z; Wen Y; Pan J; Jiang X; Yan Y; Liu P; Liu F; Li P DNA Cell Biol; 2020 Sep; 39(9):1532-1544. PubMed ID: 32644844 [TBL] [Abstract][Full Text] [Related]
12. N6-methyladenosine-related lncRNAs identified as potential biomarkers for predicting the overall survival of Asian gastric cancer patients. Xu S; Chen W; Wang Y; Zhang Y; Xia R; Shen J; Gong X; Liang Y; Xu J; Tang H; Zhao T; Zhang Y; Chen T; Wang C BMC Cancer; 2022 Jul; 22(1):721. PubMed ID: 35778697 [TBL] [Abstract][Full Text] [Related]
13. Identification of a novel inflammatory-related gene signature to evaluate the prognosis of gastric cancer patients. Hu JL; Huang MJ; Halina H; Qiao K; Wang ZY; Lu JJ; Yin CL; Gao F World J Gastrointest Oncol; 2024 Mar; 16(3):945-967. PubMed ID: 38577477 [TBL] [Abstract][Full Text] [Related]
14. Development and validation of pyroptosis-related lncRNAs prediction model for bladder cancer. Lia T; Shao Y; Regmi P; Li X Biosci Rep; 2022 Jan; 42(1):. PubMed ID: 35024796 [TBL] [Abstract][Full Text] [Related]
15. Identification of a pyroptosis-associated long non-coding RNA signature for predicting the immune status and prognosis in skin cutaneous melanoma. Wu L; Liu G; He YW; Chen R; Wu ZY Eur Rev Med Pharmacol Sci; 2021 Sep; 25(18):5597-5609. PubMed ID: 34604952 [TBL] [Abstract][Full Text] [Related]
16. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer. Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K Front Immunol; 2022; 13():947802. PubMed ID: 36405735 [TBL] [Abstract][Full Text] [Related]
17. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer. Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X Front Immunol; 2022; 13():1056932. PubMed ID: 36479114 [TBL] [Abstract][Full Text] [Related]
18. Novel m7G-related lncRNA signature for predicting overall survival in patients with gastric cancer. Zhao B; Fang F; Liao Y; Chen Y; Wang F; Ma Y; Wei C; Zhao J; Ji H; Wang D; Tang D BMC Bioinformatics; 2023 Mar; 24(1):100. PubMed ID: 36935487 [TBL] [Abstract][Full Text] [Related]
19. Pyroptosis, apoptosis, and necroptosis molecular subtype derived prognostic signature universal applicable for gastric cancer-A large sample and multicenter retrospective analysis. Huo J; Xie W; Fan X; Sun P Comput Biol Med; 2022 Oct; 149():106037. PubMed ID: 36044785 [TBL] [Abstract][Full Text] [Related]
20. Development of a Novel Pyroptosis-Associated lncRNA Biomarker Signature in Lung Adenocarcinoma. Wang P; Wang Z; Lin Y; Castellano L; Stebbing J; Zhu L; Peng L Mol Biotechnol; 2024 Feb; 66(2):332-353. PubMed ID: 37154865 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]